Black Cohosh Formulation for Chemotherapy Eyebrow Hair Loss
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for chemotherapy-induced alopecia, particularly affecting eyebrow hair, are unsatisfactory as they either fail to prevent hair loss or have adverse effects, and there is a lack of effective methods specifically targeting eyebrow hair due to its unique growth characteristics.
Innovation Solution
A composition comprising 2-40% black cohosh extract, 0.5-20% nonionic surfactant, and 40-97.5% hydroxylated solvent is used topically to reduce and prevent eyebrow hair loss in chemotherapy patients, offering a formulation that includes a 20% solution of black cohosh in hydroxylated solvent with additional components like polysorbate 20 and isopropanol.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If black cohosh is used to prevent scalp hair loss, then androgenic alopecia is treated, but it does not effectively prevent eyebrow hair loss due to different growth characteristics
Solution Approach 1:
The patent applies local quality by formulating a composition specifically tailored for eyebrow hair characteristics. The composition includes black cohosh extract at 2-40% concentration, which is optimized for the shorter growth cycle and single-strand growth pattern of eyebrow hair, rather than using formulations designed for scalp hair. This localized formulation addresses the specific needs of eyebrow hair follicles.
Solution Approach 2:
The patent employs parameter changes by adjusting the concentration of black cohosh extract to 2-40%, which is higher than typical scalp hair formulations. This parameter adjustment accounts for the shorter anagen phase of eyebrow hair (4 months vs. 3-4 years for scalp hair), requiring more concentrated active ingredients to achieve effective prevention during the brief growth period.
2Reliability
If chemotherapeutic agents are administered to treat cancer, then tumor growth is inhibited, but rapid cell division in hair follicles is damaged causing alopecia
Solution Approach 1:
The patent applies preliminary anti-action by administering the black cohosh-containing composition to eyebrow hair follicles before chemotherapy treatment begins. This pre-treatment establishes protective effects in the hair follicles, creating resistance to the cytotoxic effects of chemotherapeutic agents. The composition is continued during chemotherapy to maintain protection, countering the hair loss effect before it fully manifests.
Solution Approach 2:
The patent uses black cohosh extract as an intermediary substance that mediates between the chemotherapeutic agents and the hair follicle cells. The composition acts as a protective intermediary, allowing cancer treatment to proceed while shielding the rapidly dividing hair follicle cells from the harmful effects of chemotherapy through the protective properties of black cohosh.
3Reliability
If a composition is formulated to prevent eyebrow hair loss, then hair retention is improved, but formulation stability and efficacy must be maintained
Solution Approach 1:
The patent applies composite materials by formulating a complex composition containing black cohosh extract (2-40%), nonionic surfactant (0.5-20%), and hydroxylated solvent (40-97.5%). This composite formulation combines multiple ingredients with complementary functions: black cohosh provides the active protective effect, the nonionic surfactant ensures proper delivery and penetration, and the hydroxylated solvent provides stability and solubility. The synergistic combination maintains both efficacy and formulation stability.
Data Source
AI summary
Compositions comprising from about 2 to about 40 percent by weight of black cohosh extract, from about 0.5 to about 20 percent by weight of nonionic surfactant, and from about to 40 about 97.5 percent by weight of hydroxylated solvent are effective in reducing and preventing eyebrow hair loss in patients undergoing chemotherapy.